Ex-Meta and DeepMind researchers raised $650m at a $4.65bn valuation for Recursive Superintelligence, a startup betting AI can automate its own research.

Incisive essays, intimate memoirs, and offbeat works of fiction contemplate the nature of motherhood and familial ...

With "Project Hail Mary" dominating the box office, author Andy Weir is steering fans toward Blake Crouch’s mind-bending ...

Project Hail Mary author Andy Weir keeps on recommending this sci-fi book everywhere he goes, and it's not hard to understand ...

The City and Its Uncertain Walls review explores Haruki Murakami’s latest novel on memory, identity and loss in a quiet, ...

Plus, pizza drama in the pizza capital, a podcast about your espresso machine, and Goop Kitchen arrives in New York ...

Recursion Pharmaceuticals' AI-driven Recursion OS platform shows strong potential but has yet to demonstrate a clear competitive edge. Read more on RXRX stock here.

Swapping paramours, hobbies, and physical features to meet the pop-culture moment, the Kardashians both shape and reflect the Zeitgeist.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...